0
ARTICLE |

Quinidine-Induced Lupus Erythematosus-Reply

Carl J. Lavie, MD; Jack Waxman, MD
Arch Intern Med. 1985;145(9):1740-1741. doi:10.1001/archinte.1985.00360090216042.
Text Size: A A A
Published online

We believe that the patient described by Drs Krainin and Clark had quinidine-induced systemic lupus erythematosus (SLE). Interestingly, their patient and four of the five patients we described had speckled antinuclear antibodies (ANAs) associated with quinidine therapy; most patients with drug-induced lupus have homogeneous ANAs. Since first reporting our cases of quinidine-induced SLE, we have become aware of three additional published cases of drug-induced lupus associated with quinidine therapy.1,2 Including three cases published only in abstract form3 and the case described by Drs Krainin and Clark, we now know of 15 cases of quinidine-induced lupus erythematosus published in the English literature. In addition, after presenting our five cases to the American Rheumatism Association (San Antonio, Tex, June 3, 1983), rheumatologists in attendance informed us of numerous unpublished cases of SLE induced by quinidine therapy that they had managed in their private or university practices. We agree with the

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs